Get started
Author

Alan T. Paciorek

Observed names: A T Paciorek, A. Paciorek, Alan Paciorek, Alan T Paciorek, Paciorek, Alan
Observed institutions: Brigham and Women's Hospital, Emory University, University of California, San Francisco, Vanderbilt University, University of California San Francisco Medical Center, UCSF Helen Diller Family Comprehensive Cancer Center, Winship Cancer Institute
ORCID: 0000-0003-3900-882X
Observed ORCID: 0000-0003-3900-882X
OpenAlex ID: A5015057673
Impact of Ethnicity on Primary Treatment Choice and Mortality in Men With Prostate Cancer: Data From CaPSURE
2010 · Kelvin A. Moses, Alan T. Paciorek, et al. · Journal of Clinical Oncology · 110
PDF
A Model That Predicts the Probability of Positive Imaging in Prostate Cancer Cases With Biochemical Failure After Initial Definitive Local Therapy
2008 · Toni K. Choueiri, Robert Dreicer, et al. · The Journal of Urology · 107
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
2019 · Samantha K. Greaney, Alain P. Algazi, et al. · Cancer Immunology Research · 97
Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSURE™
2008 · Y. Mark Hong, Jim C. Hu, et al. · Urologic Oncology Seminars and Original Investigations · 66
A Case–Control Study to Evaluate Environmental and Lifestyle Risk Factors for Esophageal Cancer in Tanzania
2020 · Elia J. Mmbaga, Beatrice P. Mushi, et al. · Cancer Epidemiology Biomarkers & Prevention · 52
Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: An analysis from the CaPSURE registry
2013 · K. Clint Cary, Alan Paciorek, et al. · Cancer · 39
PDF
Traveling young injection drug users at high risk for acquisition and transmission of viral infections
2008 · Judith A. Hahn, Kimberly Page-Shafer, et al. · Drug and Alcohol Dependence · 37
Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram
2012 · A Kutikov, M R Cooperberg, et al. · Prostate Cancer and Prostatic Diseases · 36
Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases
2019 · Daniel H. Kwon, Alan Paciorek, et al. · Pancreas · 33
3D: diversity, dynamics, differential testing – a proposed pipeline for analysis of next-generation sequencing T cell repertoire data
2017 · Li Zhang, Jason Cham, et al. · BMC Bioinformatics · 33
PDF
Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer
2020 · Carling Ursem, Margaret Zhou, et al. · The Oncologist · 27
Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse.
2014 · Xabier Garcia-Albeniz, June M. Chan, et al. · Journal of Clinical Oncology · 26
PDF
Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy
2009 · Robert Abouassaly, Alan Paciorek, et al. · Cancer · 24
Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes
2021 · Rebecca J. DeBoer, Victoria Umutoni, et al. · Gynecologic Oncology · 21
PDF
Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments
2013 · Jeanette M. Broering, Alan Paciorek, et al. · Quality of Life Research · 17
Attitudes and Barriers to Research Among Oncology Trainees in East Africa
2019 · Fidel Rubagumya, Sarah K. Nyagabona, et al. · The Oncologist · 16
The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy
2024 · Surekha Yadav, Courtney Lawhn-Heath, et al. · Journal of Nuclear Medicine · 15
PDF
Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation
2020 · Rebecca J. DeBoer, Cyprien Shyirambere, et al. · JCO Global Oncology · 14
Postoperative radiation therapy for patients at high‐risk of recurrence after radical prostatectomy: does timing matter?
2015 · Charles C. Hsu, Alan T. Paciorek, et al. · British Journal of Urology · 13
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms
2021 · Katherine S. Chen, Courtney Lawhn-Heath, et al. · PLoS ONE · 12
PDF
Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time
2023 · Stephanie J. Wang, Julia Whitman, et al. · Journal of Neuroendocrinology · 11
Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review
2023 · Bryan Khuong Le, Patrick McGarrah, et al. · Clinical Genitourinary Cancer · 10
Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma
2023 · Marissa B Savoie, Alan Paciorek, et al. · The Journal of Sexual Medicine · 10
PDF
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies
2020 · Jason Cham, Li Zhang, et al. · Journal for ImmunoTherapy of Cancer · 10
PDF
Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study
2022 · Geoffrey C. Buckle, Alita Mrema, et al. · BMC Cancer · 9
PDF
Works count: 98
Citation count: 928
H-index: 16
I10-index: 24
Year
Topic
Type